A Phase I Dose-escalation Trial of vvDD-CDSR (Double-deleted Vaccinia Virus Plus CD/ SMR) Administered by Intratumoral Injection or Intravenous Injection.
Phase of Trial: Phase I
Latest Information Update: 26 Jan 2016
At a glance
- Drugs JX 929 (Primary) ; JX 929 (Primary)
- Indications Breast cancer; Colorectal cancer; Head and neck cancer; Liver cancer; Malignant melanoma; Pancreatic cancer; Squamous cell cancer
- Focus Adverse reactions
- 26 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Dec 2013 Planned end date changed from 1 Jun 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 06 Sep 2012 Actual initiation date changed from 1 Feb 2008 to 1 May 2008 as reported by ClinicalTrials.gov.